Igyxos announces Pierre-Henry Longeray as CEO along with raising €7.5mSeries A funding led by Bpifrance

– FRANCE, Nouzilly – Igyxos, a biotechnology company specializing in the development of a new treatment for female and male infertility, today announced the success of its € 7.5 million fundraising in the part of a Series A conducted by Bpifrance, via the Accelerate Biotechnologies Santé Fund managed by Bpifrance in the framework of the Investments for the Future Program, alongside the Go Capital Amorçage II and Loire Valley Invest Funds managed by Go Capital and the Fonds Emergence Innovation II managed by Sofimac Innovation.…